Karol Jaroch

SPME as a promising tool in translational medicine and drug discovery: From bench to bedside.

Combretastatins: In vitro structure-activity relationship, mode of action and current clinical status.

Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment.

Untargeted screening of phase I metabolism of combretastatin A4 by multi-tool analysis.

The use of solid phase microextraction for metabolomic analysis of non-small cell lung carcinoma cell line (A549) after administration of combretastatin A4.